Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach (Q35161796)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach |
scientific article |
Statements
1 reference
Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach (English)
1 reference
Janice M Mehnert
1 reference
Antoinette R Tan
1 reference
Rebecca Moss
1 reference
Elizabeth Poplin
1 reference
Mark N Stein
1 reference
Mika Sovak
1 reference
Kelly Levinson
1 reference
Hongxia Lin
1 reference
Michael Kane
1 reference
Murugesan Gounder
1 reference
Yong Lin
1 reference
Weichung Joe Shih
1 reference
Eric H Rubin
1 reference
Vassiliki Karantza
1 reference
16 June 2011
1 reference
1 reference
10
1 reference
8
1 reference
1509-1519
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference